AUTOLOGOUS STEM CELL TRANSPLANTATION AS FRONT LINE THERAPY DOES NOT IMPROVE THE OUTCOME OF HIGH RISK AGGRESSIVE NON-HODGKIN'S LYMPHOMA: A SINGLE CENTER STUDY

被引：0
|
作者：
Won, J. -H [1 ]
Yun, J. [1 ]
Kim, H. J. [1 ]
Kim, K. H. [1 ]
Kim, S. -H [1 ]
Lee, S. -C [1 ]
Kim, H. J. [1 ]
Bae, S. B. [1 ]
Kim, C. K. [1 ]
Lee, N. S. [1 ]
Lee, K. -T [1 ]
Park, S. K. [1 ]
Hong, D. S. [1 ]
Park, H. S. [1 ]
机构：
[1] Soonchunhyang Univ Hosp, Seoul, South Korea
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.301
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
271
引用
收藏
页码：S252 / S252
页数：1
相关论文
共 50 条
  • [41] Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin’s lymphoma
    Panagiotis Tsirigotis
    Liliane Dray
    Igor B. Resnick
    Aliza Ackerstein
    Benjamin Gesundheit
    Sharon Elad
    Reuven Or
    Michael-Yechiel Shapira
    Annals of Hematology, 2010, 89 : 263 - 272
  • [42] Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma
    Horwitz, SM
    Negrin, RS
    Blume, KG
    Breslin, S
    Stuart, MJ
    Stockerl-Goldstein, KE
    Johnston, LJ
    Wong, RM
    Shizuru, JA
    Horning, SJ
    BLOOD, 2004, 103 (03) : 777 - 783
  • [43] Stem Cell Transplantation for Non-Hodgkin's Lymphoma
    Wrench, David
    Gribben, John G.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2008, 22 (05) : 1051 - +
  • [44] Stem-cell transplantation in non-Hodgkin's lymphoma:: improving outcome
    Gianni, AM
    Berinstein, NL
    Evans, PAS
    López-Guillermo, A
    Solano, C
    ANTI-CANCER DRUGS, 2002, 13 : S35 - S42
  • [45] Autologous stem cell transplantation in treatment of patients with non-Hodgkin lymphoma - our center experience
    Simic, L.
    Tukic, L.
    Tarabar, O.
    Stamatovic, D.
    Glavicic, V.
    Balint, B.
    Elez, M.
    Madjaru, L.
    Marjanovic, S.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S319 - S319
  • [46] High-dose chemotherapy with autologous stem cell support does not improve outcome in the first-line treatment of aggressive non-Hodgkin lymphoma - Results of a comprehensive meta-analysis
    Greb, A
    Bohlius, J
    Schwarzer, G
    Schiefer, D
    Engert, A
    ANNALS OF ONCOLOGY, 2005, 16 : 55 - 55
  • [47] OUTCOME OF PATIENTS WITH TRANSFORMED INDOLENT NON-HODGKIN LYMPHOMA REFERRED FOR AUTOLOGOUS STEM CELL TRANSPLANTATION
    Villa, D.
    Crump, M.
    Keating, A.
    Ambler, K.
    Kuruvilla, J.
    ANNALS OF ONCOLOGY, 2011, 22 : 188 - 189
  • [48] Modified BEAM with triple autologous stem cell transplantation for patients with relapsed aggressive non-Hodgkin lymphoma
    Karin Hohloch
    Samira Zeynalova
    Björn Chapuy
    Michael Pfreundschuh
    Markus Loeffler
    Marita Ziepert
    Alfred C. Feller
    Lorenz Trümper
    Dirk Hasenclever
    Gerald Wulf
    Norbert Schmitz
    Annals of Hematology, 2016, 95 : 1121 - 1128
  • [49] Autologous Stem Cell Transplantation in the Management of Relapsed Non-Hodgkin Lymphoma
    Alencar, Alvaro J.
    Moskowitz, Craig H.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (05) : 467 - +
  • [50] Autologous hematopoietic cell transplantation in non-Hodgkin's lymphoma
    Johnston, LJ
    Horning, SJ
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (05) : 889 - +
12345